69 related articles for article (PubMed ID: 4039918)
1. [Corticosteroid as an anti-emetic agent in cancer chemotherapy with cis-diammine-dichloroplatinum (II)].
Samma S; Yoshikawa M; Futami T; Hayashi Y; Horii Y; Kubota K; Babaya K; Hirao Y; Okajima E; Ohara S
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):561-5. PubMed ID: 4039918
[TBL] [Abstract][Full Text] [Related]
2. [Antiemetic effect of timiperone and methylprednisolone in cisplatin-induced emesis].
Tsujii T; Tari K; Yonese J; Kojima S
Gan To Kagaku Ryoho; 1988 Jul; 15(7):2101-5. PubMed ID: 3395137
[TBL] [Abstract][Full Text] [Related]
3. [A comparative study of the effects of granisetron alone and a combination of granisetron plus steroids on CDDP-based combination chemotherapy-induced emesis--outcomes of a multicenter randomized comparative study using the central registration method. Nara Medical University Kytril Study Group].
Ozono S; Okajima E; Hirao YK; Natsume O; Kaneko Y; Ohara S; Tabata S; Watanabe S; Aoyama H; Sasaki K; Matsuki H; Takashima K; Maruyama Y; Yoshikawa M; Yamada K; Momose H; Hiramatsu T; Hayashi Y; Babaya K; Shiomi T
Gan To Kagaku Ryoho; 1997 Feb; 24(3):349-56. PubMed ID: 9051139
[TBL] [Abstract][Full Text] [Related]
4. [Effect of CDDP administration on NK activity of human peripheral lymphocytes and its modification by corticosteroid as anti-emetic agent].
Takahashi K; Saijo N; Seki S; Kimata M; Sasaki Y; Shimizu E; Eguchi K; Shinkai T; Tominaga K; Hoshi A
Gan To Kagaku Ryoho; 1984 Mar; 11(3):492-6. PubMed ID: 6538405
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of clinical effects between granisetron alone and combination of granisetron and methylprednisolone against the nausea and vomiting induced by CDDP chemotherapy--comparative study by the cross-over trial. University of Tsukuba Antiemetics Study Group].
Uchida K; Akaza H; Shimazui T; Kikuchi K; Manabe F; Iwasaki A; Ishikawa S; Noguchi R; Otani M; Hattori K; Kondo F; Nishijima Y; Sato K; Koiso K; Hinotsu S
Gan To Kagaku Ryoho; 1996 Jan; 23(1):81-6. PubMed ID: 8546475
[TBL] [Abstract][Full Text] [Related]
6. [Granisetron versus granisetron plus methylprednisolone in the prevention of chemotherapy induced nausea and vomiting--in adjuvant chemotherapy, including CDDP against gastric cancer].
Kurita A; Takashima S; Nakata M; Kubo Y; Saiki T; Ohsumi S; Yokoyama N; Tanada M; Takiyama W; Saeki H
Gan To Kagaku Ryoho; 1997 Jan; 24(1):49-54. PubMed ID: 9020945
[TBL] [Abstract][Full Text] [Related]
7. [A randomized cross-over comparative study of granisetron alone and combination of granisetron, methylprednisolone and droperidol as antiemetic prophilaxis in CDDP-based chemotherapy for gynecologic cancer].
Wataba K; Sagae S; Fukunaka N; Sugimura M; Akutagawa N; Hayashi T; Yamana K; Nakamura T; Terasawa K; Mizumoto H; Kitajima Y; Kudo R
Gan To Kagaku Ryoho; 1997 Apr; 24(6):691-7. PubMed ID: 9126306
[TBL] [Abstract][Full Text] [Related]
8. [Combination effect of granisetron plus corticosteroid for prevention of cisplatin-induced emesis: a cross-over study comparing methylprednisolone and dexamethasone].
Tanaka K; Sekine M; Serikawa T; Sanada H; Shichiri K; Fujimori R
Gan To Kagaku Ryoho; 1998 May; 25(6):907-13. PubMed ID: 9617330
[TBL] [Abstract][Full Text] [Related]
9. Prevention of cisplatin-induced acute and delayed emesis by the selective neurokinin-1 antagonists, L-758,298 and MK-869.
Van Belle S; Lichinitser MR; Navari RM; Garin AM; Decramer ML; Riviere A; Thant M; Brestan E; Bui B; Eldridge K; De Smet M; Michiels N; Reinhardt RR; Carides AD; Evans JK; Gertz BJ
Cancer; 2002 Jun; 94(11):3032-41. PubMed ID: 12115394
[TBL] [Abstract][Full Text] [Related]
10. [Anti-emetic effects of ondansetron hydrochloride throughout courses of cytotoxic chemotherapy].
Nishida T; Yakushiji M; Ohizumi K; Noda S; Rikimaru T; Matsuoka K
Gan To Kagaku Ryoho; 2002 Jan; 29(1):81-7. PubMed ID: 11816483
[TBL] [Abstract][Full Text] [Related]
11. The antiemetic effect of methylprednisolone in patients treated with cis-platinum (CDDP) for advanced testicular germ cell tumors.
Salvioni R; Faustini M; Piva L; Pasi M; Pizzocaro G
Chemioterapia; 1984 Aug; 3(4):223-6. PubMed ID: 6099753
[TBL] [Abstract][Full Text] [Related]
12. [Comparative trial of granisetron alone and granisetron plus methylprednisolone for prevention of nausea and vomiting during cancer chemotherapy].
Hisano C; Nakano S; Okuma K; Masumoto N; Fujishima H; Nakamura M; Niho Y
Gan To Kagaku Ryoho; 1996 Aug; 23(9):1175-81. PubMed ID: 8751806
[TBL] [Abstract][Full Text] [Related]
13. [Clinical efficacy of GG032X tablets, a new dosage form of ondansetron (fast dispersing tablet), on cisplatin-induced nausea and emesis].
Ariyoshi Y; Nukariya N; Akasaka Y; Suminaga M; Ota J; Ikeda M; Taguchi T
Gan To Kagaku Ryoho; 1997 Jun; 24(8):995-1011. PubMed ID: 9212810
[TBL] [Abstract][Full Text] [Related]
14. [Does the addition of an anxiolytic drug improve the anti-emetic effectiveness of the steroid and granisetron combination in the prophylaxis of cisplatin-induced vomiting?].
Lehoczky O; Bagaméri A; Sárosi Z; Kulcsár T; Pulay T
Orv Hetil; 2001 Aug; 142(31):1681-4. PubMed ID: 11556262
[TBL] [Abstract][Full Text] [Related]
15. [Amelioration of cisplatin-induced vomiting and anorexia by methylprednisolone].
Matsumoto I; Aikawa T; Kanda T; Hara K
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):833-8. PubMed ID: 2712580
[TBL] [Abstract][Full Text] [Related]
16. The oral NK(1) antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy: a combined analysis of two randomised, placebo-controlled phase III clinical trials.
de Wit R; Herrstedt J; Rapoport B; Carides AD; Guoguang-Ma J; Elmer M; Schmidt C; Evans JK; Horgan KJ
Eur J Cancer; 2004 Feb; 40(3):403-10. PubMed ID: 14746859
[TBL] [Abstract][Full Text] [Related]
17. Comparison of ondansetron-dexamethasone-lorazepam versus metoclopramide-dexamethasone-lorazepam in the control of cisplatin induced emesis.
Manusirivithaya S; Chareoniam V; Isariyodom P; Sungsab D
J Med Assoc Thai; 2001 Jul; 84(7):966-72. PubMed ID: 11759977
[TBL] [Abstract][Full Text] [Related]
18. [Anti-emetic treatment for patients with non-small cell lung cancer after chemotherapy, usefulness of preventive combination of anti-emetic agents and importance of psychiatric aspect of patients].
Inoue S; Endo K; Ichimura H; Endo K
Gan To Kagaku Ryoho; 1999 May; 26(6):813-9. PubMed ID: 10410151
[TBL] [Abstract][Full Text] [Related]
19. [Improvement in the control of chemotherapy induced emesis with ondansetron, methylprednisolone and lorazepam combination in patients treated by a moderate emetic treatment and uncontrolled by a previous antiemetic combination].
Harousseau JL; Zittoun R; Bonneterre J; Hedouin M; Ouvry J
Bull Cancer; 2000 Jun; 87(6):491-7. PubMed ID: 10903790
[TBL] [Abstract][Full Text] [Related]
20. [Randomized comparative trial of a new anti-emetic: nabilone, in cancer patients treated with cisplatin].
George M; Pejovic MH; Thuaire M; Kramar A; Wolff JP
Biomed Pharmacother; 1983; 37(1):24-7. PubMed ID: 6311306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]